The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

MS meditation, whether through mindfulness, breathwork, or guided walking, can help you manage the stress of living with the disease.

The FDA rejected Sanofi's MS drug tolebrutinib, citing liver injury risks, unclear benefits, and trial data that failed to ...

Multiple sclerosis diagnosed in people under 18 is called pediatric MS or pediatric-onset multiple sclerosis (POMS). It’s associated with more frequent relapses but a slower accumulation of disability ...

Researchers have developed a way to use three types of microscopic imaging techniques simultaneously to analyze living tissue and learn more about the molecular mechanisms of multiple sclerosis, ...

As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...

Two decades of clinical experience with the immunomodulatory treatment of multiple sclerosis points to distinct immunological pathways that drive disease relapses and progression. Although the ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

We know so much more about multiple sclerosis (MS) than we used to. But one important theme is that we’ve become much better at treating the relapsing form of this disease and changing its natural ...

Prof Nicholas Schwab and his colleagues found a biomarker which allows to tell in advance if therapy with glatirameracetate will be efficient in an individual MS patent. Treatment with interferon or ...